Figure 6From: Characterization of bortezomib-adapted I-45 mesothelioma cellsBcl-2 family protein expression following the bortezomib treatment. I-45 and I-45-BTZ-R cells were treated with 40 nM bortezomib for 24, 48, or 72 hours. Expression of Bcl-xL, Mcl-1, Bax, noxa, or p53 was determined by Western blot analysis.Back to article page